Sata Michio | 久留米大学先端癌治療研究センター

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
Human primary cultured hepatic stellate cells can be cryopreserved
High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
Case-control study for the identification of virological factors associated with fulminant hepatitis B
Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
Periostin and bone marrow fibrosis
Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
Keratin inclusions alter cytosolic protein localization in hepatocytes
Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
Angiogenic cell therapy for hepatic fibrosis
Timing of interferon therapy and sources of infection in patients with acute hepatitis C
Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
Hepatitis B virus genotype G is an extremely rare genotype in Japan
Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

もっと見る

スポンサーリンク